An app-based nonpharmacological intervention improves patient-reported disease activity, functionality, and quality of life in patients with axial spondyloarthritis: a randomised controlled trial - Pu
3 hours ago
- #axial spondyloarthritis
- #mobile health
- #nonpharmacological intervention
- An app-based nonpharmacological intervention called Axia was evaluated for patients with axial spondyloarthritis (axSpA).
- Axia combines personalized exercise therapy, patient education, disease management, and gamification for adherence.
- A 12-week randomized controlled trial involved 200 axSpA patients, with 186 completing the study (95 in intervention, 91 in control).
- The intervention group showed significant improvements in disease activity (BASDAI), functionality, and quality of life compared to the control group.
- More patients in the intervention group achieved ASAS20 (51% vs 9%) and ASAS40 (23% vs 3%) responses.
- No safety concerns were reported, supporting Axia as a safe and effective addition to conventional pharmacotherapy.